ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association of Serum Hepatitis B Virus RNA With Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Under Nucleos(t)ide Analogues Therapy

Liu, Shi; Deng, Rui; Zhou, Bin; Liang, Xieer; Liu, Zhihong; Peng, Jie; Chen, Jinjun; Zhou, Yuanping; Guo, Yabing; Chen, Yongpeng; Li, Wanying; Shen, Sheng; Lu, Xingyu; Zhao, Siru; Liao, Xingmei; Liang, Hongyan; Lan, Yu; Hou, Jinlin; Fan, Rong; Sun, Jian*南方医科大学
JOURNAL OF INFECTIOUS DISEASES2022-9-13DOI: 10.1093/infdis/jiab597
11被引11阅读
引用收藏
分享

摘要

High level of serum HBV RNA, a surrogate marker of intrahepatic cccDNA, is associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide analogues. Achieving undetectable HBV RNA could be a valuable endpoint of antiviral treatment. @@@ Background Whether serum hepatitis B virus (HBV) RNA associates with hepatocellular carcinoma (HCC) development in chronic hepatitis B (CHB) patients has not been fully elucidated. Methods We enrolled 2974 patients receiving nucleos(t)ide analogues (NAs) from a prospective, observational CHB cohort to investigate the effect of serum HBV RNA, measured at study entry (baseline), on HCC development, using Cox regression analyses. Results During median follow-up of 4.4 years, 90 patients developed HCC. Patients with detectable baseline HBV RNA (n = 2072) exhibited significantly higher HCC risk than those with undetectable level (5-year HCC incidence estimated by Kaplan-Meier method: 4.1% versus 1.8%, P = .009; adjusted hazard ratio [aHR] = 2.21, P = .005). HBV RNA levels of 609-99 999 and >= 100 000 copies/mL were associated with incrementally increasing HCC risk (aHR = 2.15 and 3.05, respectively; P for trend = .003), compared to undetectable level (<609 copies/mL). Moreover, patients with single-detectable either HBV DNA or RNA and double-detectable DNA and RNA had 1.57- and 4.02-fold higher HCC risk, respectively, than those with double-undetectable DNA and RNA (P for trend = .001). Conclusions High-level HBV RNA is associated with increased HCC risk in NAs-treated patients. Achieving undetectable HBV RNA may contribute to better clinical outcomes, indicating it could be a valuable endpoint of anti-HBV treatment.

学科与关键词

关键词
hepatitis B virus RNAliver cancernucleos(t)ide analoguesrisk factor
相关
加载中…
  • ASSOCIATION BETWEEN SERUM HBV RNA AND RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDER ANTIVIRAL THERAPY
    Liu, Shi; Deng, Rui; Zhou, Bin; Liang, Xieer; Liu, Zhihong; Peng, Jie; Chen, Jinjun; Zhou, Yuanping; Guo, Yabing; Chen, Yongpeng; Li, Wanying; Shen, Sheng; Lu, Xingyu; Zhao, Siru; Liao, Xingmei; Liang, Hongyan; Lan, Yu; Hou, Jinlin; Fan, Rong; Sun, Jian
  • Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment
    Xia, Muye; Chi, Heng; Wu, Yaobo; Hansen, Bettina E.; Li, Zhandong; Liu, Shi; Liao, GuiChan; Zhang, Xiaoyong; Zhou, Bin; Hou, Jinlin; Sun, Jian; Janssen, Harry L. A.*; Peng, Jie*Alimentary Pharmacology and Therapeutics, 2021, 54(5): 709-714.被引 13
  • Circulating HBV RNA: From biology to clinical applications
    Deng, Rui; Liu, Shi; Shen, Sheng; Guo, Haitao*; Sun, Jian*Hepatology, 2022, 76(5): 1520-1530.被引 11
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF INFECTIOUS DISEASES
发表日期
2022-09-13
卷期
第 226 卷, 第 5 期
页码
881-890
DOI
10.1093/infdis/jiab597
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81871668, 82070614, 81772187, 82170610, 81802011, 82100637]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]

作者

  • L

    Liu, Shi (第一作者)

    southern med univ

  • D

    Deng, Rui

    southern med univ

查看全部 20 位作者收起作者
  • Z

    Zhou, Bin

    southern med univ

  • L

    Liang, Xieer

    southern med univ

  • L

    Liu, Zhihong

    southern med univ

  • P

    Peng, Jie

    southern med univ

  • C

    Chen, Jinjun

    southern med univ

  • Z

    Zhou, Yuanping

    southern med univ

  • G

    Guo, Yabing

    southern med univ

  • C

    Chen, Yongpeng

    southern med univ

  • L

    Li, Wanying

    southern med univ

  • S

    Shen, Sheng

    southern med univ

  • L

    Lu, Xingyu

    southern med univ

  • Z

    Zhao, Siru

    southern med univ

  • L

    Liao, Xingmei

    southern med univ

  • L

    Liang, Hongyan

    southern med univ

  • L

    Lan, Yu

    southern med univ

  • H

    Hou, Jinlin

    southern med univ

  • F

    Fan, Rong

    southern med univ

  • S

    Sun, Jian (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417